Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease

Figure 8 Improvement of serum parameters and cytokines by fecal microbiota transplantation in metabolic dysfunction-associated steatotic liver disease rats. A: Study schematic; B: The contents of serum alanine aminotransferase, aspartate transaminase, total cholesterol, triglyceride, n = 6; C: The concentrations of tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and IL-18, n = 6. ^aP < 0.05, ^bP < 0.01. Statistical analysis was conducted using one-way analysis of variance with Tukey’s post hoc test, and results are presented as mean ± SD. ALT: Alanine aminotransferase; AST: Aspartate transaminase; FMT: Fecal microbiota transplantation; IL: Interleukin; MET: Metformin; SFF: Sterile fecal filtrate; TC: Total cholesterol; TG: Triglyceride; TNF-α: Tumor necrosis factor-α.